Tag: Pfizer

COVID-19-vaccine
Covid-19 vaccine: Pfizer CEO claims medicine could be ready by October

New York: Global pharmaceutical major Pfizer believes that a Covid-19 vaccine could be ready by the end of October, the company’s CEO Albert Bourla said. Pfizer is conducting clinical trials in the US and Europe for the BNT162 vaccine programme to prevent Covid-19 in collaboration with German mRNA company BioNTech. Bourla made the comments while […]

  • Friday, 16 April 2021
COVID-Vaccine
COVID-19 Vaccine Will Be Ready By Year End In 'Best Case Scenario': Pfizer

New York: Pfizer, which has struck a nearly $2 billion deal with the US government to deliver 100 million doses of a COVID-19 vaccine developed in collaboration with its German partner BioNTech, is hoping to seek regulatory approval for a vaccine “as early as October” this year and have a vaccine on the market by […]

  • Wednesday, 14 April 2021
COVID-19-Vaccine
Covid Vaccine: Pfizer, BioNTech Begin Late Stage Clinical Trials

New York: US-based Pfizer and German biotech firm BioNTech have announced the start of a late stage clinical trial of a Covid-19 vaccine jointly developed by the two companies. The Phase 2/3 study will involve up to 30,000 participants between 18 and 85 years of age, the two companies said on Monday. The vaccine candidate, […]

  • Wednesday, 14 April 2021
Trump
Trump Accuses FDA And Pfizer Of Withholding COVID-19 Vaccine Announcement Before Elections

Washington: US President Donald Trump on Monday accused the Food and Drug Administration (FDA) and Pfizer of withholding the announcement on COVID-19 vaccine before elections to prevent him from getting a “vaccine win”. The US Food and Drug Administration “and the Democrats didn’t want to have me get a Vaccine WIN, prior to the election, […]

  • Friday, 09 April 2021
Sensex Hits 43,000-Mark For First Time; Nifty Tops 12,600
Sensex Hits 43,000-Mark For First Time; Nifty Tops 12,600

Mumbai: Extending its winning streak for the seventh straight session, equity benchmark Sensex soared 680 points to scale another lifetime high on Tuesday, tracking a global market rally driven by Pfizer’s COVID-19 vaccine trials data. After touching its lifetime peak of 43,316.44 during the day, the 30-share BSE index ended 680.22 points or 1.60 per […]

  • Friday, 09 April 2021
Coronavirus
Indian Vaccines Don't Need Temperature As Low As Pfizer's: AIIMS Director

New Delhi: Indian vaccines offer a lot of hope, due to various factors including a good safety signal, display of immunogenicity and capability of using the current storage infrastructure, said AIIMS Director Randeep Guleria in an exclusive interview with IANS. Recently, drug company Pfizer announced that its vaccine candidate for Covid-19 is more than 90 […]

  • Friday, 09 April 2021
Pfizer
Pfizer COVID19 Vaccine 95% Effective, Seeks Emergency Clearance

New York: Pfizer and its German partner BioNTech released a second batch of interim results on Wednesday, saying their coronavirus vaccine candidate is 95 per cent effective and also protects the most vulnerable people in older age groups from the risk of falling prey to the virus. “Primary efficacy analysis demonstrates BNT162b2 to be 95 […]

  • Friday, 09 April 2021
Oxford Covid-19 Vaccine ‘Encouraging' For Older Age Groups
Covid-19 Vaccine: Odisha May Face Cold Chain Challenge

Bhubaneswar: Even as the race of potential vaccine for Covid-19 is approaching the last lap, the cold-chain infrastructure is likely to emerge as biggest hurdle for Odisha, say experts. The State government has started a road map in full swing for procurement, preservation and distribution of the vaccine as Prime Minister Narendra Modi on Friday […]

  • Friday, 09 April 2021
Pfizer
First Americans 'Could Get Vaccine On December 11th': White House Vaccine Chief

Washington: The first Americans to receive a COVID-19 vaccine could get it as soon as December 11 or 12, the White House vaccine czar said on Sunday. On Friday, American pharmaceutical giant Pfizer and its German partner BioNTech submitted an application to the US Food and Drug Administration for emergency use authorisation for its COVID-19 […]

  • Friday, 09 April 2021
COVID Vaccine
Pfizer Seeks Emergency Use Authorisation For Its COVID-19 Vaccine In India

New Delhi: Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India (DCGI) an emergency use authorisation for its COVID-19 vaccine in the country, after its parent company secured such clearance in the UK and Bahrain. The firm, in its application submitted to the drug regulator, has sought permission […]

  • Thursday, 08 April 2021
Margaret-Keenan
90-Yr-Old Granny First To Receive Pfizer Shot As Mass COVID-19 Vaccination Begins In Britain

London: Margaret Keenan, a 90-year-old woman from Northern Ireland on Tuesday became the first person in the world to receive the Pfizer/BioNTech COVID-19 vaccine – marking the start of the UK’s mass vaccination programme against the deadly disease. Keenan, from Enniskillen, said she felt “so privileged” to receive the jab at University Hospital, Coventry. Keenan became […]

  • Thursday, 08 April 2021
Pfizer
COVID-19 Vaccine: Pfizer Withdraws Emergency Use Authorisation Application In India

New Delhi: Pharma major Pfizer on Friday said it has decided to withdraw its application for Emergency Use Authorisation (EUA) of its COVID-19 vaccine in India. Pfizer was the first pharmaceutical firm to seek an emergency use authorisation from the Drugs Controller General of India (DCGI) for its COVID-19 vaccine in the country, after it […]

  • Monday, 05 April 2021
S Africa Variant Could Reduce Covid Vaccine Protection: Pfizer-BioNTech

New York: The South African variant of Covid-19 may significantly reduce antibody protection from the Pfizer-BioNTech vaccine, as per a laboratory study, the pharmaceutical companies said. However, human trials are still to be conducted in this regard. According to the study, published in The New England Journal of Medicine, although the results indicated a reduction […]

  • Monday, 05 April 2021
Pfizer-Vaccine
Pfizer Covid-19 Vaccine Wins Crucial Approval As US Cases Soars

New York: After nine hours of non-stop debate, a high powered US vaccine advisory panel endorsed mass use of the Pfizer-BioNTech Covid-19 vaccine, putting the country just one step away from a historic vaccination campaign against a virus that has killed more than 292,000 Americans. Shots could come within days. The US Food and Drug […]

  • Monday, 01 March 2021
Covid-19 Vaccine: US FDA Authorizes Emergency Use Of Pfizer,
Covid-19 Vaccine: US FDA Authorizes Emergency Use Of Pfizer, Hails Scientists

New York: The US Food and Drug Administration (FDA) have approved the emergency use of the country’s first Covid-19 vaccine from Pfizer and its German partner BioNTech for people aged 16 years and older. “The FDA’s authorisation for emergency use of the first Covid-19 vaccine is a significant milestone in battling this devastating pandemic that […]

  • Monday, 01 March 2021
scrollToTop